Anogenital cancers testing in San Ferdinando di Puglia
Find health labs to test for Anogenital cancers in San Ferdinando di Puglia and compare all offers by prices and services.
Tests that cover Anogenital cancers
HPV Test
Pap Test by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€65.00
€61.75 with our promocode
See Details
test HPV cavo orale autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€65.00
€61.75 with our promocode
See Details
Pap Smear by Laboratorio Lifebrain
Via Giuseppe Palmitessa, 18 76121 Barletta (BA)
10.9 km
Pap Smear by Laboratorio Lifebrain
Via Ferdinando D’Argona, 92/B 76121 Barletta (BAT)
10.9 km
Pap Smear by Laboratorio Lifebrain
Via Eduardo de Filippo, 52B, 71042 Cerignola (Foggia)
18.8 km
Pap Smear by Laboratorio Lifebrain
Via A. De Gasperi, 78 76014 Spinazzola (BAT)
22.9 km
Pap Smear by Laboratorio Lifebrain
Via Aldo Moro, 2 CAP 85028 PZ Rionero In Vulture (Potenza)
33 km
Pap Smear by Laboratorio Lifebrain
Piazza Cavour, 27 70024 Gravina in Puglia (BA)
37.9 km
Pap Smear by Laboratorio Lifebrain
Via Scipione Ronchetti, 15 70022 Altamura (BA)
41.3 km
Pap Smear by Laboratorio Lifebrain
Via G. Matteotti, 24 70121 Bari (BA)
43.2 km
Pap Test by Laboratorio di analisi cliniche Cusmai
Via Demetrio Marin, 3, 70125 Bari BA, Italia
43.2 km
Pap Smear by Laboratorio Lifebrain
Via Michele Donnanno, 40 71015 San Nicandro Garganico (FG)
45.5 km
Anogenital cancers - symptoms and how to test
Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.
